Literature DB >> 23918466

Bioactivation and toxicity of acetaminophen in a rat hepatocyte micropatterned coculture system.

Okechukwu Ukairo1, Michael McVay, Stacy Krzyzewski, Simon Aoyama, Kelly Rose, Melvin E Andersen, Salman R Khetani, Edward L Lecluyse.   

Abstract

We have recently shown that primary rat hepatocytes organized in micropatterned cocultures with murine embryonic fibroblasts (HepatoPac™) maintain high levels of liver functions for at least 4 weeks. In this study, rat HepatoPac was assessed for its utility to study chemical bioactivation and associated hepatocellular toxicity. Treatment of HepatoPac cultures with acetaminophen (APAP) over a range of concentrations (0-15 mM) was initiated at 1, 2, 3, or 4 weeks followed by the assessment of morphological and functional endpoints. Consistent and reproducible concentration-dependent effects on hepatocyte structure, viability, and basic functions were observed over the 4-week period, and were exacerbated by depleting glutathione using buthionine sulfoximine or inducing CYP3A using dexamethasone, presumably due to increased reactive metabolite-induced stress and adduct formation. In conclusion, the results from this study demonstrate that rat HepatoPac represents a structurally and functionally stable hepatic model system to assess the long-term effects of bioactivated compounds.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Acetaminophen; Bioactivation; Cocultures; Micropatterning; Rat Hepatocytes

Mesh:

Substances:

Year:  2013        PMID: 23918466     DOI: 10.1002/jbt.21512

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  3 in total

1.  A microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles.

Authors:  Lei Li; Kurtulus Gokduman; Aslihan Gokaltun; Martin L Yarmush; Osman Berk Usta
Journal:  Nanomedicine (Lond)       Date:  2019-06-10       Impact factor: 5.307

2.  Metabolic behavior prediction of pazopanib by cytochrome P450 (CYP) 3A4 by molecular docking.

Authors:  Xing-Jie Liu; Hua Lu; Ju-Xiang Sun; Su-Rong Wang; Yan-Shuai Mo; Xing-Sheng Yang; Ben-Kang Shi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-03-04       Impact factor: 2.441

3.  MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.

Authors:  Richard Kia; Lorna Kelly; Rowena L C Sison-Young; Fang Zhang; Chris S Pridgeon; James A Heslop; Pete Metcalfe; Neil R Kitteringham; Melissa Baxter; Sean Harrison; Neil A Hanley; Zoë D Burke; Mike P Storm; Melanie J Welham; David Tosh; Barbara Küppers-Munther; Josefina Edsbagge; Philip J Starkey Lewis; Frank Bonner; Ernie Harpur; James Sidaway; Joanne Bowes; Stephen W Fenwick; Hassan Malik; Chris E P Goldring; B Kevin Park
Journal:  Toxicol Sci       Date:  2014-12-18       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.